GSK3B and familial pancreatic carcinoma: In the following studies, we investigated the effects of GSK-3β expression on the sensitivity of the MIA-PaCa-2 pancreatic cancer and the MCF-7 breast cancer cell lines to various chemotherapeutic drugs, signal transduction inhibitors, and nutraceuticals.